2m 2m 2m 2m 2m 2m 2m
ADVANCED BIOMED (ADVB)
NASDAQ
$8.02+$0.02 (+0.25%)
Price as of Aug 03, 2026 11:30 AM EDT- $13.2MMarket Cap
- -6.41%1-Year Change
- Diagnostics & ResearchIndustry
ADVANCED BIOMED (ADVB)
$8.02+$0.02 (+0.25%)
ADVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.00 | ||
Change | -$2.08 (-20.63%) | ||
Open | $9.65 | ||
High | $9.81 | ||
Low | $7.91 | ||
Previous Close | $10.08 | ||
Volume | 102,726 | ||
30-Day Average Volume | 4,772,729 | ||
1-Week Change | -57.85% | ||
1-Month Change | 72.05% | ||
1-Year Change | -6.41% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $10.6M | ||
Market Cap | $13.2M | ||
Enterprise Value | $11.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$488,942.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$488,830.00 | ||
EBITDA | -$479,504.00 | ||
Net Working Capital | N/A | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -21 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/20/2026 | ||